Human digestive and metabolic lipases - A brief review

Journal of Molecular Catalysis B: Enzymatic

Volumn 22, Issue 5-6, 2003, Pages 369-376

  Mukherjee, Manjari ^a  

^a Cumballa Hill Hospital   (India)

Author keywords

Anti lipase agents; Anti obesity agents; Fibrates; Heparin; Lipase

Indexed keywords

CATALYST ACTIVITY; HUMAN ENGINEERING; LIPIDS; METABOLISM;

LIPASES;

ENZYMES;

ALKALOID DERIVATIVE; BERBERINE; ENZYME INHIBITOR; KIDNEY ENZYME; LIPOPROTEIN LIPASE; LIVER ENZYME; LIVER TRIACYLGLYCEROL LIPASE; LUNG ENZYME; MUSCLE ENZYME; PANCREAS ENZYME; PHOSPHOLIPASE A1; PLACENTA ENZYME; PROCOAGULANT; SANGUINARINE; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL LIPASE;

ADIPOSE TISSUE; CANDIDA RUGOSA; CANDIDIASIS; CHROMOSOME 10Q; CHROMOSOME 15Q; CHROMOSOME 18Q; CHROMOSOME 8P; CYSTIC FIBROSIS; DRUG CONTRAINDICATION; DRUG INDICATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME REPLACEMENT; ENZYME STABILITY; GENE FUNCTION; GENE LOCATION; HEART; HUMAN; HYPERLIPIDEMIA; INFECTION CONTROL; KIDNEY PARENCHYMA; LIVER; LUNG PARENCHYMA; MULTIGENE FAMILY; NONHUMAN; OBESITY; PANCREAS; PLACENTA; PROTEIN FUNCTION; REVIEW; SEQUENCE HOMOLOGY; SKELETAL MUSCLE; STOMACH ABSORPTION; TISSUE DISTRIBUTION;

EID: 0038353706     PISSN: 13811177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1381-1177(03)00052-3     Document Type: Article

References (68)

1. P.A. Mayes, Metabolism of lipids. I. Fatty acids, in: Harper's Review of Biochemistry, 19th ed., Lange Medical Publications, Singapore, 1983, pp. 201-223.
2. Mukherjee M. Lipoproteins and apolipoproteins - function, metabolism and disorder. Bombay Hosp. J. 35:1993;75-82.
3. Phan C.T., Tso P. Intestinal lipid absorption and transport. Front. Biosci. 6:2001;D299-D319.
4. Choi S.Y., Hirata K., Ishida T., Quertermous T., Cooper A.D. Endothelial lipase: a new lipase on the block. J. Lipid Res. 43:2002;1763-1769.
5. DeNigris S.J., Hamosh M., Kasbekar D.K., Lee T.C., Hamosh P. Lingual and gastric lipases: species differences in the origin of pre-pancreatic digestive lipases and in the localization of gastric lipase. Biochim. Biophys. Acta. 959:1988;38-45.
6. Hamosh M. Lingual and gastric lipase. Nutrition. 6:1990;421-428.
7. Moreau H., Laugier R., Gargouri Y., Ferrato F., Verger R. Human pre-duodenal lipase is entirely of gastric fundic origin. Gastroenterology. 95:1988;1221-1226.
8. Lohse P., Lohse P., Chahrokh-Zadeh S., Seidel D. The acid lipase gene family: three enzymes, one highly conserved gene structure. J. Lipid Res. 38:1997;880-891.
9. Bodmer M.W., Angal S., Yarranton G.T., Harris T.J.R., Lyons A., King D.J., Pieroni G., Riviere C., Verger R., Lowe P.A. Molecular cloning of human gastric lipase and expression of the enzyme in yeast. Biochim. Biophys. Acta. 909:1987;237-244.
10. Bernbaeck S., Blaeckberg L. Human gastric lipase. The N-terminal tetrapeptide is essential for lipid binding and lipase activity. Eur. J. Biohem. 182:1989;495-499.
11. Hide W.A., Chan L., Li W.H. Structure and evolution of the lipase superfamily. J. Lipid Res. 33:1992;167-178.
12. Kirchgessner T.G., Svenson K.L., Lusis A.J., Schotz M.C. The sequence of cDNA encoding lipoprotein lipase. A member of a lipase gene family. J. Biol. Chem. 262:1987;8463-8466.
13. Lowe M.E., Rosenblum J.L., Strauss A.W. Cloning and characterization of human pancreatic lipase cDNA. J. Biol. Chem. 264:1989;20042-20048.
14. Sims H.F., Jennens M.L., Lowe M.E. The human pancreatic lipase-encoding gene: structure and conservation of an Alu sequence in the lipase gene family. Gene. 131:1993;281-285.
15. Datta S., Luo C.C., Li W.H., Vantuinen P., Ledbetter D.H., Brown M.A., Chen S.H., Liu S., Chan L. Human hepatic lipase. Cloned cDNA sequence, restriction fragment length polymorphisms, chromosomal localization, and evolutionary relationships with lipoprotein and pancreatic lipase. J. Biol. Chem. 263:1988;1107-1110.
16. Ameis D., Stahnke G., Kobayashi J., McLean J., Lee G., Buscher M., Schotz M.C., Will H. Isolation and characterization of the human hepatic lipase gene. J. Biol. Chem. 265:1990;6552-6555.
17. Wion K.L., Kirchgessner T.G., Lusis A.J., Schotz M.C., Lawn R.M. Human lipoprotein lipase complementary DNA sequence. Science. 235:1987;1638-1641.
18. Hirata K.-I., Dichek H.L., Cioffi J.A., Choi S.Y., Leeper N.J., Quintana L., Kronmal G.S., Cooper A.D., Quertermous T. Cloning of a unique lipase from endothelial cells extends the lipase gene family. J. Biol. Chem. 274:1999;14170-14175.
19. Jaye M., Lynch K.J., Krawiec J., Marchadier D., Maugeais C., Doan K., South V., Amin D., Perrone M., Rader D.J. A novel endothelial-derived lipase that modulates HDL metabolism. Nat. Genet. 21:1999;424-428.
20. Esposito S., Semeriva M., Desnuelle P. Effect of surface pressure on the hydrolysis of ester monolayers by pancreatic lipase. Biochim. Biophys. Acta. 302:1973;293-304.
21. Lagocki J., Law J., Kezdy F. The kinetic study of enzyme action on substrate monolayers. Pancreatic lipase reactions. J. Biol. Chem. 248:1973;580-587.
22. Lowe M.E. Molecular mechanisms of rat and human pancreatic triglyceride lipases. J. Nutr. 127:1997;549-557.
23. Brockman H.L. Kinetic behaviour of the pancreatic lipase-colipase-lipid system. Biochimie. 82:2000;987-995.
24. P.N. Howles, D.Y. Hui, Cholesterol esterase, in: C. Mansbach, P. Tso, A. Kuksis (Eds.), Intestinal Lipid Metabolism, Kluwer Academic Publishers, Dordrecht, pp. 119-134.
25. Falt H., Hernell O., Blackberg L. Do human bile-salt-stimulated lipase and colipase-dependent pancreatic lipase share a common heparin-containing receptor? Arch. Biochem. Biophys. 386:2001;188-194.
26. J.D. Brunzell, in: C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.), Metabolic Basis of Inherited Disease, McGraw-Hill, New York, 1989, pp. 1165-1180.
27. Camp L., Reina M., Llobera M., Vilaro S., Olivecrona T. Lipoprotein lipase: cellular origin and functional distribution. Am. J. Physiol. 258:1990;C673-C681.
28. Sivaram P., Klein M.G., Goldberg I.J. Identification of a heparin-releasable lipoprotein lipase binding protein from endothelial cells. J. Biol. Chem. 267:1992;16517-16522.
29. T. Olivecrona, G. Bengtsson-Olivecrona, Heparin and lipases, in: D.A. Lane, U. Lindahl (Eds.), Heparin. Chemical and Biological Properties Clinical Applications, Edward Arnold, London, 1989, pp. 335-361.
30. Santamarina-Fojo S., Dugi K.A. Structure, function and role of lipoprotein lipase in lipoprotein metabolism. Curr. Opin. Lipidol. 5:1994;117-125.
31. Emmerich J., Beg O.U., Peterson J., Previato L., Brunzell J.D., Brewer H.B. Jr., Santamarina-Fojo S. Human lipoprotein lipase. Analysis of catalytic triad by site-directed mutagenesis of Ser-132, Asp-156 and His-241. J. Biol. Chem. 267:1992;4161-4165.
32. Bengtsson G., Olivecrona T. Lipoprotein lipase. Mechanism of product inhibition. Eur. J. Biochem. 106:1980;557-562.
33. L. Stryer, Biochemistry, fourth ed., Freeman, New York, 1995, pp. 603-606.
34. Persoon N.L., Hulsmann W.C., Jansen H. Localization of salt-resistant heparin-releasable lipase in the rat liver, adrenal and ovary. Eur. J. Cell Biol. 41:1986;134-137.
35. Mukherjee M., Scully M.F., Kakkar V.V., Phillipou H., Lane D.A., Jewitt D. Decrease in factor VII coagulant activity during percutaneous transluminal coronary angioplasty by heparin-mediated lipolytic action. Thromb. Haemost. 77:1997;675-678.
36. G. Bengtsson-Olivecrona, T. Olivecrona, Assay of lipoprotein lipase and hepatic lipase, in: C.A. Converse, E.R. Skinner (Eds.), Lipoprotein Analysis. A Practical Approach, Oxford University Press, Oxford, 1992, pp. 169-185.
37. Connelly P.W. The role of hepatic lipase in lipoprotein metabolism. Clin. Chim. Acta. 286:1999;243-255.
38. Hayden M.R., Ma Y., Brunzell J., Henderson H.E. Genetic variants affecting human lipoprotein and hepatic lipases. Curr. Opin. Lipidol. 2:1991;104-109.
39. Reymer P.W.A., Gagne E., Groenmeyer B.E., Zhang H., Forsyth I., Jansen H., Seidell J.C., Kromhout D., Lie K.E., Kastelein J.J., Hayden M.R. A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis. Nat. Genet. 10:1995;28-34.
40. Wittrup H.H., Tybjjaerg-Hansen A., Abildgaard S., Steffensen R., Schnohr P., Nordestgaard B.G. A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease. J. Clin. Invest. 99:1997;1606-1613.
41. Guerra R., Wang J., Grundy S.M., Cohen J.C. A hepatic lipase (LIPC) allele is associated with high plasma concentrations of high density lipoprotein cholesterol. Proc. Natl. Acad. Sci. U.S.A. 94:1997;4532-4537.
42. McCoy M.G., Sun G.S., Marchadier D., Maugeais C., Glick J.M., Rader D.J. Characterization of lipolytic activity of endothelial lipase. J. Lipid Res. 43:2002;921-929.
43. Hegnhoj J., Hansen C.P., Rannem T., Sobrik H., Anderson L.B., Anderson J.R. Pancreatic function in Crohn's disease. Gut. 31:1990;1076-1079.
44. FritzSimmons S.C., Burkhart G.A., Borowitz D., Grand R.J., Hammerstrom T., Durie P.R., Lloyd-Still J.D., Lowenfels A.B. High-dose pancreatic enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N. Engl. J. Med. 336:1997;1283-1289.
45. Stehr F., Felk A., Kretschmar M., Schaller M., Schafer W., Hube B. Extracellular hydrolytic enzymes and their relevance during Candida albicans infection. Mycoses. 43:2000;17-21.
46. Hube B., Stehr F., Bossenz M., Manzur A., Kretschmar M., Schafer W. Secreted lipases of Candida albicans: cloning, characterization and expression analysis of a new gene family with at least 10 members. Arch. Microbiol. 174:2000;362-374.
47. Grippa E., Valla R., Battinelli L., Mazzanti G., Saso L., Silvestrini B. Inhibition of Candida rugosa lipase by berberine and structurally related alkaloids evaluated by high-performance liquid chromatography. Biosci. Biotechnol. Biochem. 63:1999;1557-1562.
48. Bray G.A. A concise review on the therapeutics of obesity. Nutrition. 16:2000;953-960.
49. Weibel E.K., Hadvary P., Hochuli E., Kupfer E., Lengsfeld H. Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. I. Producing organism, fermentation, isolation and biological activity. J. Antibiot. (Tokyo). 40:1987;1081-1085.
50. Haputman J.B., Jeunet F.S., Hartmann D. Initial studies in human with the novel gastrointestinal lipase inhibitor Ro 18-0647 (tetrahydrolipstatin). Am. J. Clin. Nutr. 55:1992;3095-3135.
51. Toplak H., Marhardt K. Reduction of obesity and improvement in metabolic parameters by inhibition of intestinal lipases: current results with Orlistat. Acta Med. Aust. 25:1998;142-145.
52. Kotsovolou S., Chiou A., Verger R., Kokotos G. Bis-2-oxo amide triacylglycerol analogues: a novel class of potent human gastric lipase inhibitors. J. Org. Chem. 66:2001;962-967.
53. Chiou A., Verger R., Kokotos G. Synthetic routes and lipase-inhibitory activity of long chain α-keto amides. Lipids. 36:2001;535-542.
54. Yamamoto M., Shimura S., Itoh Y., Ohsaka T., Egawa M., Inoue S. Anti-obesity effects of lipase inhibitor CT-II, an extract from edible herbs, Nomame herba, on rats fed a high-fat diet. Int. J. Obes. Relat. Metab. Disord. 24:2000;758-764.
55. Erlanson-Albertsson C., York D. Enterostatin: a peptide regulating fat intake. Obes. Res. 5:1997;360-372.
56. Gotto A.M. Jr. Reviews and news on the role of lipids in coronary heart disease. Lipid Rev. 1:1987;1-8.
57. Thompson G.R. Primary hyperlipidemia. Br. Med. Bull. 46:1990;986-1004.
58. Knopp R.H. Drug treatment of lipid disorders. N. Engl. J. Med. 341:1999;498-511.
59. Shepherd J. Mechanism of action of fibrates. Postgrad. Med. J. 69(Suppl. 1):1993;S34-S41.
60. Nikkila E.A., Huttunen J.K., Ehnholm C. Effect of clofibrate on post-heparin plasma triglyceride lipase activities in patients with hypertriglyceridemia. Metabolism. 26:1977;179-186.
61. Guo Q., Wang P.R., Milot D.P., Ippolito M.C., Hernandez M., Burton C.A., Wright S.D., Chao Y. Regulation of lipid metabolism and gene expression by fenofibrate in hamsters. Biochim. Biophys. Acta. 1533:2001;220-232.
62. Kashyap M. The effect of gemfibrozil on plasma lipids and lipoproteins in man. Vasc. Med. 2:1984;16-21.
63. Auwerx J., Schoonjans K., Fruchart J.-C., Staels B. Transcriptional control of triglyceride metabolism: fibrates and fatty acids change the expression of LPL and apo C-III genes by activating the nuclear receptor PPAR. Atheroscler. Suppl. 124:1996;S29-S37.
64. Piorunska-Stolzmann M., Piorunska-Mikolajczak A. The influence of simvastatin on lipase and cholesterol esterase activity in the serum of men with coronary heart disease. Pharmacol. Res. 43:2001;359-362.
65. Sandset P.M. Tissue factor pathway inhibitor (TFPI) - an update. Haemostasis. 26:1996;154-165.
66. Mukherjee M., Kakkar V.V. Enhancement of lipoprotein lipase activity by tissue factor pathway inhibitor. Thromb. Haemost. 82:1999;1648-1651.
67. Mukherjee M., Dawson G., Sembhi K., Kakkar V.V. Triglyceride dependence of factor VII coagulant activity in deep venous thrombosis. Thromb. Haemost. 76:1996;500-501.
68. Mukherjee M., Ranlall N., Patel G., Rutlin A., Jehanli A., Kakkar V.V. Anticoagulant versus amidolytic activity of tissue factor pathway inhibitor in coronary artery disease. Blood Coagul. Fibrinol. 11:2000;285-291.